<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38767144</PMID><DateCompleted><Year>2024</Year><Month>05</Month><Day>20</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>27</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1096-9071</ISSN><JournalIssue CitedMedium="Internet"><Volume>96</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>May</Month></PubDate></JournalIssue><Title>Journal of medical virology</Title><ISOAbbreviation>J Med Virol</ISOAbbreviation></Journal><ArticleTitle>Nanomedicine-mediated recovery of antioxidant glutathione peroxidase activity after oxidative-stress cellular damage: Insights for neurological long COVID.</ArticleTitle><Pagination><StartPage>e29680</StartPage><MedlinePgn>e29680</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/jmv.29680</ELocationID><Abstract><AbstractText>Nanomedicine for treating post-viral infectious disease syndrome is at an emerging stage. Despite promising results from preclinical studies on conventional antioxidants, their clinical translation as a therapy for treating post-COVID conditions remains challenging. The limitations are due to their low bioavailability, instability, limited transport to the target tissues, and short half-life, requiring frequent and high doses. Activating the immune system during coronavirus (SARS-CoV-2) infection can lead to increased production of reactive oxygen species (ROS), depleted antioxidant reserve, and finally, oxidative stress and neuroinflammation. To tackle this problem, we developed an antioxidant nanotherapy based on lipid (vesicular and cubosomal types) nanoparticles (LNPs) co-encapsulating ginkgolide B and quercetin. The antioxidant-loaded nanocarriers were prepared by a self-assembly method via hydration of a lyophilized mixed thin lipid film. We evaluated the LNPs in a new in vitro model for studying neuronal dysfunction caused by oxidative stress in coronavirus infection. We examined the key downstream signaling pathways that are triggered in response to potassium persulfate (KPS) causing oxidative stress-mediated neurotoxicity. Treatment of neuronally-derived cells (SH-SY5Y) with KPS (50&#x2009;mM) for 30&#x2009;min markedly increased mitochondrial dysfunction while depleting the levels of both glutathione peroxidase (GSH-Px) and tyrosine hydroxylase (TH). This led to the sequential activation of apoptotic and necrotic cell death processes, which corroborates with the crucial implication of the two proteins (GSH-Px and TH) in the long-COVID syndrome. Nanomedicine-mediated treatment with ginkgolide B-loaded cubosomes and vesicular LNPs showed minimal cytotoxicity and completely attenuated the KPS-induced cell death process, decreasing apoptosis from 32.6% (KPS) to 19.0% (MO-GB), 12.8% (MO-GB-Quer), 14.8% (DMPC-PEG-GB), and 23.6% (DMPC-PEG-GB-Quer) via free radical scavenging and replenished GSH-Px levels. These findings indicated that GB-LNPs-based nanomedicines may protect against KPS-induced apoptosis by regulating intracellular redox homeostasis.</AbstractText><CopyrightInformation>&#xa9; 2024 The Author(s). Journal of Medical Virology published by Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Akanchise</LastName><ForeName>Thelma</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Universit&#xe9; Paris-Saclay, CNRS, Institut Galien Paris-Saclay, Orsay, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Angelov</LastName><ForeName>Borislav</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Extreme Light Infrastructure ERIC, Department of Structural Dynamics, Dolni Brezany, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Angelova</LastName><ForeName>Angelina</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-0285-0637</Identifier><AffiliationInfo><Affiliation>Universit&#xe9; Paris-Saclay, CNRS, Institut Galien Paris-Saclay, Orsay, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>European Regional Development Fund</Agency><Country/></Grant><Grant><Agency>European Commission</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Med Virol</MedlineTA><NlmUniqueID>7705876</NlmUniqueID><ISSNLinking>0146-6615</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000975">Antioxidants</NameOfSubstance></Chemical><Chemical><RegistryNumber>DF149B9460</RegistryNumber><NameOfSubstance UI="C045856">ginkgolide B</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D046934">Ginkgolides</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.11.1.9</RegistryNumber><NameOfSubstance UI="D005979">Glutathione Peroxidase</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007783">Lactones</NameOfSubstance></Chemical><Chemical><RegistryNumber>9IKM0I5T1E</RegistryNumber><NameOfSubstance UI="D011794">Quercetin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017382">Reactive Oxygen Species</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000975" MajorTopicYN="Y">Antioxidants</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000093485" MajorTopicYN="Y">COVID-19 Drug Treatment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D046934" MajorTopicYN="Y">Ginkgolides</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005979" MajorTopicYN="Y">Glutathione Peroxidase</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007783" MajorTopicYN="N">Lactones</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050997" MajorTopicYN="Y">Nanomedicine</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053758" MajorTopicYN="Y">Nanoparticles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="Y">Oxidative Stress</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011794" MajorTopicYN="N">Quercetin</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017382" MajorTopicYN="N">Reactive Oxygen Species</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ginkgolide B</Keyword><Keyword MajorTopicYN="N">glutathione peroxidase</Keyword><Keyword MajorTopicYN="N">long COVID syndrome</Keyword><Keyword MajorTopicYN="N">nanomedicine</Keyword><Keyword MajorTopicYN="N">oxidative stress</Keyword><Keyword MajorTopicYN="N">quercetin</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>4</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>20</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>20</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>20</Day><Hour>6</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38767144</ArticleId><ArticleId IdType="doi">10.1002/jmv.29680</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Varahachalam SP, Lahooti B, Chamaneh M, et al. Nanomedicine for the SARS&#x2010;CoV&#x2010;2: state&#x2010;of&#x2010;the&#x2010;art and future prospects. Int J Nanomedicine. 2021;16:539&#x2010;560. doi:10.2147/IJN.S283686</Citation></Reference><Reference><Citation>Hald Albertsen C, Kulkarni JA, Witzigmann D, Lind M, Petersson K, Simonsen JB. The role of lipid components in lipid nanoparticles for vaccines and gene therapy. Adv Drug Deliv Rev. 2022;188:114416. doi:10.1016/j.addr.2022.114416</Citation></Reference><Reference><Citation>Mainardes RM, Diedrich C. The potential role of nanomedicine on COVID&#x2010;19 therapeutics. Ther Delivery. 2020;11(7):411&#x2010;414. doi:10.4155/tde-2020-0069</Citation></Reference><Reference><Citation>Premraj L, Kannapadi NV, Briggs J, et al. Mid and long&#x2010;term neurological and neuropsychiatric manifestations of post&#x2010;COVID&#x2010;19 syndrome: a meta&#x2010;analysis. J Neurol Sci. 2022;434:120162. doi:10.1016/j.jns.2022.120162</Citation></Reference><Reference><Citation>Harapan BN, Yoo HJ. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS&#x2010;CoV&#x2010;2) and coronavirus disease 19 (COVID&#x2010;19). J Neurol. 2021;268(9):3059&#x2010;3071. doi:10.1007/s00415-021-10406-y</Citation></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F, for the Gemelli Against COVID&#x2010;19 Post&#x2010;Acute Care Study Group. Persistent symptoms in patients after acute COVID&#x2010;19. JAMA. 2020;324(6):603. doi:10.1001/jama.2020.12603</Citation></Reference><Reference><Citation>Delgado&#x2010;Roche L, Mesta F. Oxidative stress as key player in severe acute respiratory syndrome coronavirus (SARS&#x2010;CoV) infection. Arch Med Res. 2020;51(5):384&#x2010;387. doi:10.1016/j.arcmed.2020.04.019</Citation></Reference><Reference><Citation>Nuzzo D, Cambula G, Bacile I, et al. Long&#x2010;term brain disorders in Post Covid&#x2010;19 Neurological Syndrome (PCNS) patient. Brain Sci. 2021;11(4):454. doi:10.3390/brainsci11040454</Citation></Reference><Reference><Citation>Boroujeni ME, Simani L, Bluyssen HAR, et al. Inflammatory response leads to neuronal death in human post&#x2010;mortem cerebral cortex in patients with COVID&#x2010;19. ACS Chem Neurosci. 2021;12(12):2143&#x2010;2150. doi:10.1021/acschemneuro.1c00111</Citation></Reference><Reference><Citation>Nuzzo D, Picone P. Potential neurological effects of severe COVID&#x2010;19 infection. Neurosci Res. 2020;158:1&#x2010;5. doi:10.1016/j.neures.2020.06.009</Citation></Reference><Reference><Citation>Nair A, Sharma P, Tiwary M. Glutathione deficiency in COVID19 illness&#x2010;does supplementation help? Saudi J Anaesth. 2021;15(4):458. doi:10.4103/sja.sja_320_21</Citation></Reference><Reference><Citation>Djanaguiraman M, Boyle DL, Welti R, Jagadish SVK, Prasad PVV. Decreased photosynthetic rate under high temperature in wheat is due to lipid desaturation, oxidation, acylation, and damage of organelles. BMC Plant Biol. 2018;18(1):55. doi:10.1186/s12870-018-1263-z</Citation></Reference><Reference><Citation>Wang Q, Ma R, Liu P, et al. Efficient sustained&#x2010;release nanoparticle delivery system protects nigral neurons in a toxin model of Parkinson's disease. Pharmaceutics. 2022;14(8):1731. doi:10.3390/pharmaceutics14081731</Citation></Reference><Reference><Citation>Akanchise T, Angelova A. Ginkgo biloba and Long COVID: in vivo and in vitro models for the evaluation of nanotherapeutic efficacy. Pharmaceutics. 2023;15(5):1562. doi:10.3390/pharmaceutics15051562</Citation></Reference><Reference><Citation>Angelova A, Angelov B, Drechsler M, Bizien T, Gorshkova YE, Deng Y. Plasmalogen&#x2010;Based liquid crystalline multiphase structures involving docosapentaenoyl derivatives inspired by biological cubic membranes. Front Cell Dev Biol. 2021;9:617984. doi:10.3389/fcell.2021.617984</Citation></Reference><Reference><Citation>De Torre MP, Cavero RY, Calvo MI, Vizmanos JL. A simple and a reliable method to quantify antioxidant activity in vivo. Antioxidants. 2019;8(5):142. doi:10.3390/antiox8050142</Citation></Reference><Reference><Citation>Rolnik A, Soluch A, Kowalska I, Olas B. Antioxidant and hemostatic properties of preparations from Asteraceae family and their chemical composition&#x2014;comparative studies. Biomed Pharmacother. 2021;142:111982. doi:10.1016/j.biopha.2021.111982</Citation></Reference><Reference><Citation>Kamiloglu S, Sari G, Ozdal T, Capanoglu E. Guidelines for cell viability assays. Food Frontiers. 2020;1(3):332&#x2010;349. doi:10.1002/fft2.44</Citation></Reference><Reference><Citation>Rakotoarisoa M, Angelov B, Espinoza S, Khakurel K, Bizien T, Angelova A. Cubic liquid crystalline nanostructures involving catalase and curcumin: BioSAXS study and catalase peroxidatic function after cubosomal nanoparticle treatment of differentiated SH&#x2010;SY5Y cells. Molecules. 2019;24(17):3058. doi:10.3390/molecules24173058</Citation></Reference><Reference><Citation>Kim H, Xue X. Detection of total reactive oxygen species in adherent cells by 2&#x2032;,7&#x2032;&#x2010;Dichlorodihydrofluorescein diacetate staining. JoVE. 2020;160:60682. doi:10.3791/60682</Citation></Reference><Reference><Citation>Cossarizza A, Ferraresi R, Troiano L, et al. Simultaneous analysis of reactive oxygen species and reduced glutathione content in living cells by polychromatic flow cytometry. Nat Protoc. 2009;4(12):1790&#x2010;1797. doi:10.1038/nprot.2009.189</Citation></Reference><Reference><Citation>Amiri F, Dahaj MM, Siasi NH, Deyhim MR. Treatment of platelet concentrates with the L&#x2010;carnitine modulates platelets oxidative stress and platelet apoptosis due to mitochondrial reactive oxygen species reduction and reducing cytochrome C release during storage. J Thromb Thrombolysis. 2021;51(2):277&#x2010;285. doi:10.1007/s11239-020-02241-1</Citation></Reference><Reference><Citation>Arazi H, Mohammadjafari H, Asadi A. Use of anabolic androgenic steroids produces greater oxidative stress responses to resistance exercise in strength&#x2010;trained men. Toxicol Rep. 2017;4:282&#x2010;286. doi:10.1016/j.toxrep.2017.05.005</Citation></Reference><Reference><Citation>Sullivan&#x2010;Gunn MJ, Campbell&#x2010;O'sullivan SP, Tisdale MJ, Lewandowski PA. Decreased NADPH oxidase expression and antioxidant activity in cachectic skeletal muscle. J Cachexia Sarcopenia Muscle. 2011;2(3):181&#x2010;188. doi:10.1007/s13539-011-0037-3</Citation></Reference><Reference><Citation>Dhall S, Do DC, Garcia M, et al. Generating and reversing chronic wounds in diabetic mice by manipulating wound redox parameters. J Diabetes Res. 2014;2014:1&#x2010;18. doi:10.1155/2014/562625</Citation></Reference><Reference><Citation>Wu Y, Angelov B, Deng Y, et al. Sustained CREB phosphorylation by lipid&#x2010;peptide liquid crystalline nanoassemblies. Commun Chem. 2023;6(1):241. doi:10.1038/s42004-023-01043-9</Citation></Reference><Reference><Citation>Rakotoarisoa M, Angelov B, Garamus VM, Angelova A. Curcumin&#x2010; and fish oil&#x2010;loaded spongosome and cubosome nanoparticles with neuroprotective potential against H2 O2 &#x2010;induced oxidative stress in differentiated human SH&#x2010;SY5Y cells. ACS Omega. 2019;4(2):3061&#x2010;3073. doi:10.1021/acsomega.8b03101</Citation></Reference><Reference><Citation>Esposito E, Sguizzato M, Drechsler M, et al. Lipid nanostructures for antioxidant delivery: a comparative preformulation study. Beilstein J Nanotechnol. 2019;10:1789&#x2010;1801. doi:10.3762/bjnano.10.174</Citation></Reference><Reference><Citation>Kulkarni CV, Wachter W, Iglesias&#x2010;Salto G, Engelskirchen S, Ahualli S. Monoolein: a magic lipid? Phys Chem Chem Phys. 2011;13(8):3004&#x2010;3021. doi:10.1039/C0CP01539C</Citation></Reference><Reference><Citation>Bouffioux O, Berquand A, Eeman M, et al. Molecular organization of surfactin&#x2013;phospholipid monolayers: effect of phospholipid chain length and polar head. Biochimica et Biophysica Acta (BBA) &#x2010; Biomembranes. 2007;1768(7):1758&#x2010;1768. doi:10.1016/j.bbamem.2007.04.015</Citation></Reference><Reference><Citation>Sivadasan D, Sultan MH, Alqahtani SS, Javed S. Cubosomes in drug delivery&#x2014;a comprehensive review on its structural components, preparation techniques and therapeutic applications. Biomedicines. 2023;11(4):1114. doi:10.3390/biomedicines11041114</Citation></Reference><Reference><Citation>Angelova A, Drechsler M, Garamus VM, Angelov B. Pep&#x2010;lipid cubosomes and vesicles compartmentalized by Micelles from self&#x2010;assembly of multiple neuroprotective building blocks including a large peptide hormone PACAP&#x2010;DHA. ChemNanoMat. 2019;5(11):1381&#x2010;1389. doi:10.1002/cnma.201900468</Citation></Reference><Reference><Citation>Rakotoarisoa M, Angelov B, Espinoza S, et al. Composition&#x2010;switchable liquid crystalline nanostructures as green formulations of curcumin and fish oil. ACS Sustain Chem Eng. 2021;9(44):14821&#x2010;14835. doi:10.1021/acssuschemeng.1c04706</Citation></Reference><Reference><Citation>Fracassi A, Podolsky KA, Pandey S, et al. Characterizing the self&#x2010;assembly properties of monoolein lipid isosteres. J Phys Chem B. 2023;127(8):1771&#x2010;1779. doi:10.1021/acs.jpcb.2c07215</Citation></Reference><Reference><Citation>Zengin G, Aktumsek A. Investigation of antioxidant potentials of solvent extracts from different anatomical parts of Asphodeline Anatolica E. tuzlaci: an endemic plant to Turkey. Afr J Tradit Complement Altern Med. 2014;11(2):481. doi:10.4314/ajtcam.v11i2.37</Citation></Reference><Reference><Citation>Circu ML, Aw TY. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med. 2010;48(6):749&#x2010;762. doi:10.1016/j.freeradbiomed.2009.12.022</Citation></Reference><Reference><Citation>Ferreira CA, Ni D, Rosenkrans ZT, Cai W. Scavenging of reactive oxygen and nitrogen species with nanomaterials. Nano Res. 2018;11(10):4955&#x2010;4984. doi:10.1007/s12274-018-2092-y</Citation></Reference><Reference><Citation>Sies H, Berndt C, Jones DP. Oxidative stress. Annu Rev Biochem. 2017;86(1):715&#x2010;748. doi:10.1146/annurev-biochem-061516-045037</Citation></Reference><Reference><Citation>Di Meo S, Reed TT, Venditti P, Victor VM. Role of ROS and RNS sources in physiological and pathological conditions. Oxid Med Cell Longevity. 2016;2016:1&#x2010;44. doi:10.1155/2016/1245049</Citation></Reference><Reference><Citation>Navarro&#x2010;Yepes J, Zavala&#x2010;Flores L, Anandhan A, et al. Antioxidant gene therapy against neuronal cell death. Pharmacol Ther. 2014;142(2):206&#x2010;230. doi:10.1016/j.pharmthera.2013.12.007</Citation></Reference><Reference><Citation>Sies H, Jones DP. Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nat Rev Mol Cell Biol. 2020;21(7):363&#x2010;383. doi:10.1038/s41580-020-0230-3</Citation></Reference><Reference><Citation>Aranda&#x2010;Rivera AK, Cruz&#x2010;Gregorio A, Arancibia&#x2010;Hern&#xe1;ndez YL, Hern&#xe1;ndez&#x2010;Cruz EY, Pedraza&#x2010;Chaverri J. RONS and oxidative stress: an overview of basic concepts. Oxygen. 2022;2(4):437&#x2010;478. doi:10.3390/oxygen2040030</Citation></Reference><Reference><Citation>Popa&#x2010;Wagner A, Mitran S, Sivanesan S, Chang E, Buga AM. ROS and brain diseases: the good, the bad, and the ugly. Oxid Med Cell Longevity. 2013;2013:1&#x2010;14. doi:10.1155/2013/963520</Citation></Reference><Reference><Citation>Sharifi&#x2010;Rad J, Rapposelli S, Sestito S, et al. Multi&#x2010;target mechanisms of phytochemicals in Alzheimer's disease: effects on oxidative stress, neuroinflammation and protein aggregation. J Pers Med. 2022;12(9):1515. doi:10.3390/jpm12091515</Citation></Reference><Reference><Citation>Lee Mosley R, Benner EJ, Kadiu I, et al. Neuroinflammation, oxidative stress, and the pathogenesis of Parkinson's disease. Clin Neurosci Res. 2006;6(5):261&#x2010;281. doi:10.1016/j.cnr.2006.09.006</Citation></Reference><Reference><Citation>Abdelrahman FE, Elsayed I, Gad MK, Badr A, Mohamed MI. Investigating the cubosomal ability for transnasal brain targeting: in vitro optimization, ex vivo permeation and in vivo biodistribution. Int J Pharm. 2015;490(1&#x2010;2):281&#x2010;291. doi:10.1016/j.ijpharm.2015.05.064</Citation></Reference><Reference><Citation>Wu H, Li J, Zhang Q, et al. A novel small Odorranalectin&#x2010;bearing cubosomes: preparation, brain delivery and pharmacodynamic study on amyloid&#x2010;&#x3b2;25&#x2013;35&#x2010;treated rats following intranasal administration. Eur J Pharmaceut Biopharmaceut. 2012;80(2):368&#x2010;378. doi:10.1016/j.ejpb.2011.10.012</Citation></Reference><Reference><Citation>Cirmi S, Maugeri A, Lombardo GE, et al. A flavonoid&#x2010;rich extract of mandarin juice counteracts 6&#x2010;OHDA&#x2010;induced oxidative stress in SH&#x2010;SY5Y cells and modulates Parkinson&#x2010;related genes. Antioxidants. 2021;10(4):539. doi:10.3390/antiox10040539</Citation></Reference><Reference><Citation>Oyama Y, Chikahisa L, Ueha T, Kanemaru K, Noda K. Ginkgo biloba extract protects brain neurons against oxidative stress induced by hydrogen peroxide. Brain Res. 1996;712(2):349&#x2010;352. doi:10.1016/0006-8993(95)01440-3</Citation></Reference><Reference><Citation>Chen C, Wei T, Gao Z, et al. Different effects of the constituents of EGb761 on apoptosis in rat cerebellar granule cells induced by hydroxyl radicals. IUBMB Life. 1999;47(3):397&#x2010;405. doi:10.1080/15216549900201423</Citation></Reference><Reference><Citation>Xin W, Wei T, Chen C, Ni Y, Zhao B, Hou J. Mechanisms of apoptosis in rat cerebellar granule cells induced by hydroxyl radicals and the effects of EGb761 and its constituents. Toxicology. 2000;148(2&#x2010;3):103&#x2010;110. doi:10.1016/S0300-483X(00)00200-6</Citation></Reference><Reference><Citation>Guidetti C, Paracchini S, Lucchini S, Cambieri M, Marzatico F. Prevention of neuronal cell damage induced by oxidative stress in&#x2010;vitro: effect of different Ginkgo biloba extracts. J Pharm Pharmacol. 2010;53(3):387&#x2010;392. doi:10.1211/0022357011775442</Citation></Reference><Reference><Citation>Yang SF, Wu Q, Sun AS, Huang XN, Shi JS. Protective effect and mechanism of Ginkgo biloba leaf extracts for Parkinson disease induced by 1&#x2010;methyl&#x2010;4&#x2010;phenyl&#x2010;1,2,3,6&#x2010;tetrahydropyridine. Acta Pharmacol Sin. 2001;22(12):1089&#x2010;1093.</Citation></Reference><Reference><Citation>Alvarez&#x2010;Arellano L, Salazar&#x2010;Garc&#xed;a M, Corona JC. Neuroprotective effects of quercetin in pediatric neurological diseases. Molecules. 2020;25(23):5597. doi:10.3390/molecules25235597</Citation></Reference><Reference><Citation>Schroeter H, Spencer JPE, Rice&#x2010;Evans C, Williams RJ. Flavonoids protect neurons from oxidized low&#x2010;density&#x2010;lipoprotein&#x2010;induced apoptosis involving c&#x2010;Jun N&#x2010;terminal kinase (JNK), c&#x2010;Jun and caspase&#x2010;3. Biochem J. 2001;358(3):547&#x2010;557. doi:10.1042/bj3580547</Citation></Reference><Reference><Citation>Shi C, Zhao L, Zhu B, et al. Protective effects of Ginkgo biloba extract (EGb761) and its constituents quercetin and ginkgolide B against &#x3b2;&#x2010;amyloid peptide&#x2010;induced toxicity in SH&#x2010;SY5Y cells. Chemico&#x2010;Biol Interact. 2009;181(1):115&#x2010;123. doi:10.1016/j.cbi.2009.05.010</Citation></Reference><Reference><Citation>Merzoug S, Toumi ML, Tahraoui A. Quercetin mitigates Adriamycin&#x2010;induced anxiety&#x2010; and depression&#x2010;like behaviors, immune dysfunction, and brain oxidative stress in rats. Naunyn&#x2010;Schmiedeberg's Arch Pharmacol. 2014;387(10):921&#x2010;933. doi:10.1007/s00210-014-1008-y</Citation></Reference><Reference><Citation>Di Pierro F, Derosa G, Maffioli P, et al. Possible therapeutic effects of adjuvant quercetin supplementation against early&#x2010;stage COVID&#x2010;19 infection: a prospective, randomized, controlled, and open&#x2010;label study. Int J Gen Med. 2021;14:2359&#x2010;2366. doi:10.2147/IJGM.S318720</Citation></Reference><Reference><Citation>Derosa G, Maffioli P, D'Angelo A, Di Pierro F. A role for quercetin in coronavirus disease 2019 (COVID&#x2010;19). Phytother Res. 2021;35(3):1230&#x2010;1236. doi:10.1002/ptr.6887</Citation></Reference><Reference><Citation>Achete de Souza G, de Marqui SV, Matias JN, Guiguer EL, Barbalho SM. Effects of Ginkgo biloba on diseases related to oxidative stress. Planta Med. 2020;86(06):376&#x2010;386. doi:10.1055/a-1109-3405</Citation></Reference><Reference><Citation>Domingues RB, Mendes&#x2010;Correa MC, de Moura Leite FBV, et al. First case of SARS&#x2010;COV&#x2010;2 sequencing in cerebrospinal fluid of a patient with suspected demyelinating disease. J Neurol. 2020;267(11):3154&#x2010;3156. doi:10.1007/s00415-020-09996-w</Citation></Reference><Reference><Citation>Vollbracht C, Kraft K. Oxidative stress and hyper&#x2010;inflammation as major drivers of severe COVID&#x2010;19 and long COVID: implications for the benefit of high&#x2010;dose intravenous vitamin C. Front Pharmacol. 2022;13:899198. doi:10.3389/fphar.2022.899198</Citation></Reference><Reference><Citation>Ekambaram P, Abdul Hasan Sathali A. Formulation and evaluation of solid lipid nanoparticles of Ramipril. J Young Pharmacist. 2011;3(3):216&#x2010;220. doi:10.4103/0975-1483.83765</Citation></Reference><Reference><Citation>Bonaccorso A, Pellitteri R, Ruozi B, et al. Curcumin loaded polymeric vs. lipid nanoparticles: antioxidant effect on normal and hypoxic olfactory ensheathing cells. Nanomaterials. 2021;11(1):159. doi:10.3390/nano11010159</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>